Literature DB >> 29267140

Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.

Raf Donders1, Jeroen F J Bogie1, Stylianos Ravanidis1, Pascal Gervois1, Marjan Vanheusden1, Raphaël Marée2, Marie Schrynemackers2, Hubert J M Smeets3, Jef Pinxteren4, Kristel Gijbels4, Sara Walbers4, Robert W Mays5, Robert Deans5, Ludo Van Den Bosch6, Piet Stinissen1, Ivo Lambrichts1, Wilfried Gyselaers1,7, Niels Hellings1.   

Abstract

Mesenchymal stromal cells (MSCs) are multipotent stem cells with immunosuppressive and trophic support functions. While MSCs from different sources frequently display a similar appearance in culture, they often show differences in their surface marker and gene expression profiles. Although bone marrow is considered the "gold standard" tissue to isolate classical MSCs (BM-MSC), MSC-like cells are currently also derived from more easily accessible extra-embryonic tissues such as the umbilical cord. In this study, we defined the best way to isolate MSCs from the Wharton's jelly of the human umbilical cord (WJ-MSC) and assessed the mesenchymal and immunological phenotype of BM-MSC and WJ-MSC. Moreover, the gene expression profile of established WJ-MSC cultures was compared to two different bone marrow-derived stem cell populations (BM-MSC and multipotent adult progenitor cells or MAPC®). We observed that explant culturing of Wharton's jelly matrix is superior to collagenase tissue digestion for obtaining mesenchymal-like cells, with explant isolated cells displaying increased expansion potential. While being phenotypically similar to adult MSCs, WJ-MSC show a different gene expression profile. Gene ontology analysis revealed that genes associated with cell adhesion, proliferation, and immune system functioning are enriched in WJ-MSC. In vivo transplantation confirms their immune modulatory effect on T cells, similar to BM-MSC and MAPC. Furthermore, WJ-MSC intrinsically overexpress genes involved in neurotrophic support and their secretome induces neuronal maturation of SH-SY5Y neuroblastoma cells to a greater extent than BM-MSC. This signature makes WJ-MSC an attractive candidate for cell-based therapy in neurodegenerative and immune-mediated central nervous system disorders such as multiple sclerosis, Parkinson's disease, or amyotrophic lateral sclerosis.

Entities:  

Keywords:  MAPC; MSC; immune modulation; microarray; neurotrophic factors; umbilical cord

Mesh:

Year:  2017        PMID: 29267140     DOI: 10.1089/scd.2017.0029

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  31 in total

Review 1.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

2.  Wharton's jelly-derived mesenchymal cells as a new source for the generation of microtissues for tissue engineering applications.

Authors:  D Durand-Herrera; F Campos; B D Jaimes-Parra; J D Sánchez-López; R Fernández-Valadés; M Alaminos; A Campos; V Carriel
Journal:  Histochem Cell Biol       Date:  2018-06-11       Impact factor: 4.304

Review 3.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

4.  Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method.

Authors:  Luiza L Bagno; Alessandro G Salerno; Wayne Balkan; Joshua M Hare
Journal:  Expert Opin Biol Ther       Date:  2021-12-27       Impact factor: 4.388

5.  Transcriptional profiling reveals altered biological characteristics of chorionic stem cells from women with gestational diabetes.

Authors:  Liyun Chen; Chung-Teng Wang; Nicholas R Forsyth; Pensee Wu
Journal:  Stem Cell Res Ther       Date:  2020-07-25       Impact factor: 6.832

6.  Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs.

Authors:  Sangeetha Kandoi; Praveen Kumar L; Bamadeb Patra; Prasanna Vidyasekar; Divya Sivanesan; Vijayalakshmi S; Rajagopal K; Rama Shanker Verma
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

7.  Dose-Response Tendon-Specific Markers Induction by Growth Differentiation Factor-5 in Human Bone Marrow and Umbilical Cord Mesenchymal Stem Cells.

Authors:  Maria Camilla Ciardulli; Luigi Marino; Erwin Pavel Lamparelli; Maurizio Guida; Nicholas Robert Forsyth; Carmine Selleri; Giovanna Della Porta; Nicola Maffulli
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

Review 8.  Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer's Disease.

Authors:  Edwin E Reza-Zaldivar; Mercedes A Hernández-Sapiéns; Benito Minjarez; Yanet K Gutiérrez-Mercado; Ana L Márquez-Aguirre; Alejandro A Canales-Aguirre
Journal:  Front Cell Neurosci       Date:  2018-09-24       Impact factor: 5.505

Review 9.  Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials.

Authors:  Katarzyna Stefańska; Katarzyna Ożegowska; Greg Hutchings; Małgorzata Popis; Lisa Moncrieff; Claudia Dompe; Krzysztof Janowicz; Wojciech Pieńkowski; Paweł Gutaj; Jamil A Shibli; Walterson Mathias Prado; Hanna Piotrowska-Kempisty; Paul Mozdziak; Małgorzata Bruska; Maciej Zabel; Bartosz Kempisty; Michał Nowicki
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

10.  Neuroprotective Action of Human Wharton's Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke.

Authors:  Kuo-Jen Wu; Seong-Jin Yu; Chia-Wen Chiang; Yu-Wei Lee; B Linju Yen; Pei-Chi Tseng; Chun-Sen Hsu; Li-Wei Kuo; Yun Wang
Journal:  Cell Transplant       Date:  2018-10-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.